Supplemental studies for cardiovascular risk assessment in safety pharmacology: a critical overview. - Wikidata - awgldk - TriplyDB

Supplemental studies for cardiovascular risk assessment in safety pharmacology: a critical overview.

Supplemental studies for cardiovascular risk assessment in safety pharmacology: a critical overview.

http://www.wikidata.org/entity/Q37909132

about

Evaluation of an in silico cardiac safety assay: using ion channel screening data to predict QT interval changes in the rabbit ventricular wedge.Tuning HERG out: antitarget QSAR models for drug development Pred-hERG: A Novel web-Accessible Computational Tool for Predicting Cardiac Toxicity.An overview of QT interval assessment in safety pharmacology.Overview of safety pharmacology.Chemical toxicity prediction for major classes of industrial chemicals: Is it possible to develop universal models covering cosmetics, drugs, and pesticides?OrganDots--an organotypic 3D tissue culture platform for drug development.Adverse Drug Reactions for Medicines Newly Approved in Japan from 1999 to 2013: Hypertension and Hypotension.Alarms about structural alerts.

P2860

Q30620268-221BDBC9-0D7A-46D7-A479-6C0185105F89 Q35164442-8315A0A6-404A-46E0-911A-08809E152212 Q36095155-A83CDB16-69E4-4C3C-8D59-7ACF7BB51207 Q38112653-8648DE97-CFE4-47C1-81B3-2AA25994BA36 Q38186659-DA1A2D29-A997-413A-9F83-92F566A0DDED Q38835541-9E823BF5-1C10-42C4-A5EF-3649AF2AEDD8 Q39615996-7544FCAA-1774-42D0-A3D0-5CDFE80FD930 Q41313679-ABC859ED-3AB7-4922-A074-045955FE96B0 Q41881422-0D5E243B-5ED2-4624-A31D-148DBCBBB5A9

P2860

Supplemental studies for cardiovascular risk assessment in safety pharmacology: a critical overview.

http://www.wikidata.org/entity/Q37909132

description

article científic

@ca

article scientifique

@fr

articol științific

@ro

articolo scientifico

@it

artigo científico

@gl

artigo científico

@pt

artigo científico

@pt-br

artikel ilmiah

@id

artikull shkencor

@sq

artículo científico

@es

name

Supplemental studies for cardi ...... macology: a critical overview.

@en

Supplemental studies for cardi ...... macology: a critical overview.

@nl

type

label

Supplemental studies for cardi ...... macology: a critical overview.

@en

Supplemental studies for cardi ...... macology: a critical overview.

@nl

prefLabel

Supplemental studies for cardi ...... macology: a critical overview.

@en

Supplemental studies for cardi ...... macology: a critical overview.

@nl

P1433

Q37909132-A38AB47B-6EE5-4097-970D-C3737A6AA723

P1476

Q37909132-1BCFCBEF-B317-4C9E-A6FA-7A5B81412DD5

P2093

Q37909132-6AE30D80-AA28-4A3A-9703-3F2CE2E28638

Q37909132-89D75CDC-022A-48A2-98C7-4746E070C88F

Q37909132-B171B0BB-5811-4F9C-8DD7-F3C1971E90B6

Q37909132-C0A1D32B-4639-4B42-B47B-72D5B88C37D2

Q37909132-F5E4DC83-BEDE-4086-8B34-C6A59D6EF0A7

P2860

Q37909132-00C32115-75F1-4715-87EF-CB982E8BB9B5

Q37909132-0189B7E4-C81C-4A5C-8C0F-0D59628B7CEE

Q37909132-02411292-AD4D-4662-BE45-81EC23D711E5

Q37909132-03D72504-771F-49A2-BEF6-19A3AFC85ECB

Q37909132-0523535B-14EA-43D7-A236-8B993BD48755

Q37909132-05F0BBFC-92C1-4233-965E-E75DC5DACBE3

Q37909132-0D21C25E-FC6B-44DA-82AE-231200E4C899

Q37909132-0D547C53-ADF6-43E2-867C-48F39B0BEEA8

Q37909132-0FA6F201-DFC6-46F4-8095-0DE5856BA6C3

Q37909132-1004F60C-FA87-4180-B517-0795B6E38C39

P2888

Q37909132-DEDC136E-26CF-468E-953A-C1C3E47E8258

P304

Q37909132-DF658FCC-535E-4CC1-94FC-19AF79359AF3

P31

Q37909132-853D2A4A-36FE-4D97-94E1-8AF80677B0D3

P356

Q37909132-CBFE6270-975C-4395-9A14-263BC14E4FEE

P433

Q37909132-F3D4F77C-3442-4B08-A39C-3782EAC8C0E6

P478

Q37909132-56BF4738-F3CD-4C4A-8801-94AB179A2227

P50

Q37909132-9FC1C1FE-3011-4804-BF65-D43D77936F9F

P577

Q37909132-95EBB909-29A7-4F02-8463-FF4B20D7F040

P698

Q37909132-F069C8A4-1D96-4BED-A6DE-CD881DFE6386

P921

Q37909132-24ED27F1-F449-424F-8B8E-F6CA44C85A7A

Q37909132-B7575C7F-BD61-4B2F-9025-697D3C682A1C

P356

S12012-011-9133-Z

P1433

Cardiovascular Toxicology

P1476

Supplemental studies for cardi ...... macology: a critical overview.

@en

P2093

Joël Henry

http://www.w3.org/2001/XMLSchema#string

Philippe Guillaume

http://www.w3.org/2001/XMLSchema#string

René Rouet

http://www.w3.org/2001/XMLSchema#string

Sandra Picard

http://www.w3.org/2001/XMLSchema#string

Sonia Goineau

http://www.w3.org/2001/XMLSchema#string

P2860

Drug induced QT prolongation and torsades de pointes

Evaluation of the guinea pig monophasic action potential (MAP) assay in predicting drug-induced delay of ventricular repolarisation using 12 clinically documented drugs

Valvular heart disease associated with fenfluramine-phentermine

Torsades de pointes occurring in association with terfenadine use

A structural basis for drug-induced long QT syndrome

Sodium channel blockers identify risk for sudden death in patients with ST-segment elevation and right bundle branch block but structurally normal hearts

A randomized, multicenter comparison of tacrolimus and cyclosporine immunosuppressive regimens in cardiac transplantation: decreased hyperlipidemia and hypertension with tacrolimus

Comparative study of TA-606, a novel angiotensin II receptor antagonist, with losartan in terms of species difference and orthostatic hypotension

Properties of HERG channels stably expressed in HEK 293 cells studied at physiological temperature

Spontaneous initiation of atrial fibrillation by ectopic beats originating in the pulmonary veins

P2888

s12012-011-9133-z

P304

285-307

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S12012-011-9133-Z

http://www.w3.org/2001/XMLSchema#string

P433

4

http://www.w3.org/2001/XMLSchema#string

P478

11

http://www.w3.org/2001/XMLSchema#string

P50

Jean-Luc Hanouz

P577

2011-12-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

21805209

http://www.w3.org/2001/XMLSchema#string

P921

Aparato circulatorio